American Association of Hip and Knee Society   Report issue

Foundation Phase 4
Founded: Rosemont IL United States (1991)

Organization Overview

First Clinical Trial
2017
NCT03283878
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

American Association of Hip and Knee Society

Active Ingredients

Drugs in Phase 4 Trials (1)

cefazolin (ancef) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Joint Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1